Company intelligence / Profile preview
Restem
Miami, Florida, United Statesrestem.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
RESTEM is a clinical-stage biotechnology company developing off-the-shelf, next-generation cell therapies to modulate the immune system. Its lead product, "Restem-L"—an umbilical cord lining stem cell therapy—has shown promising results in phase 1 trials for idiopathic inflammatory myopathy with significant clinical improvement and steroid reduction. The company has received FDA Fast Track and Orphan Drug Designations for this indication and is initiating a potentially registrational phase 2/3 trial. Additional programs include secretome-based therapies and activated NK cells targeting age-related diseases.
- Therapeutic areas
- OtherImmunologyRheumatology
- Modalities
- Stem cell therapyCell therapySecretome-based therapy (Restem-X)Natural killer cell therapy (Activated NK cells)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
No major pharmaceutical or biotech partnerships disclosed as of June 2025.
Beyond the preview
Go deeper on Restem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Restem.